https://pipelinereview.com/bristol-myers-squibb-receives-positive-chmp-opinion-for-inrebic-fedratinib-for-adult-patients-with-newly-diagnosed-and-previously-treated-myelofibrosis/
Bristol Myers Squibb Receives Positive CHMP Opinion for InrebicĀ® (fedratinib) for Adult Patients with Newly Diagnosed and Previously Treated Myelofibrosis